DEFA14A: Distoken Acquisition Extends Merger Deadline with Youlife Group to June 30, 2025 Amidst Ongoing Business Combination

Distoken Acquisition Corporation and Youlife Group Inc. have amended their subscription agreements, extending the deadline for their business combination to June 30, 2025, while confirming a $27 million private placement.

Summary

• Distoken Acquisition Corporation (SPAC) and Youlife Group Inc. (Pubco), along with Youlife International Holdings Inc. (Youlife), are proceeding with a definitive business combination agreement, initially signed on May 17, 2024, and subsequently amended.
• Pubco is set to become the parent company of both Distoken and Youlife upon the consummation of the Business Combination.
• Distoken and Pubco previously entered into subscription agreements with investors for a private placement of 2,704,949 Class A ordinary shares of Pubco at $10.00 per share, totaling an aggregate purchase price of $27,049,490.
• On May 30, 2025, an amendment to these subscription agreements was executed, removing the original May 31, 2025 termination date.
• The new amendment stipulates that any party may terminate the agreement if the Business Combination is not completed by June 30, 2025.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive. While there is a delay indicated by the extension of the termination date, the continued commitment to the merger and the confirmed $27 million private placement are strong positive signals for the transaction's eventual completion.

Positives

• The amendment to the subscription agreements and the extension of the termination date indicate continued commitment from all parties to complete the business combination.
• The confirmed private placement of $27,049,490 demonstrates investor confidence and provides capital for the combined entity.

Negatives

• The necessity to extend the termination date from May 31, 2025, to June 30, 2025, suggests that the business combination was not ready for completion by the original deadline, potentially indicating unforeseen delays or complexities.

Risks

• The occurrence of any event, change, or circumstances that could lead to the termination of the Business Combination Agreement.
• Potential legal proceedings against Distoken, Youlife, Pubco, or others following the announcement of the Business Combination.
• Inability to complete the Business Combination due to failure in obtaining shareholder consents and approvals, securing necessary financing, or satisfying other closing conditions.
• Delays in obtaining, adverse conditions contained in, or inability to obtain necessary regulatory approvals.
• Changes to the proposed structure of the Business Combination required by laws, regulations, or regulatory approval conditions.
• Risks related to Youlife's and Pubco's ability to scale and grow their business, including sourcing and retaining talent.
• Challenges in meeting stock exchange listing standards post-Business Combination.
• Disruption to Youlife's current plans and operations as a result of the Business Combination announcement and consummation.
• Inability to recognize anticipated benefits of the Business Combination due to factors like competition, growth management, maintaining key relationships, and retaining management/employees.
• Costs related to the Business Combination.
• Changes in applicable laws, regulations, and broader political and economic developments.
• Adverse effects from other economic, business, and/or competitive factors.
• Failure to realize estimated shareholder redemptions, purchase price, and other adjustments.

Future Outlook

The document indicates an anticipated growth for Youlife and its products, services, and solutions, along with an expected growth in demand. It also highlights the anticipated benefits of the Business Combination and the expected timing of its completion, aiming for consummation by June 30, 2025.

Management Comments

• "Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Distoken Acquisition Corporation Date: May 30, 2025 By: /s/ Jian Zhang Name: Jian Zhang Title: Chief Executive Officer"

Industry Context

This filing is typical of a Special Purpose Acquisition Company (SPAC) nearing the completion of its de-SPAC transaction, where it merges with a private operating company (Youlife) to take it public. The extension of the merger deadline and the private investment in public equity (PIPE) financing are common elements in such complex transactions, often reflecting the challenges in meeting initial timelines and securing necessary capital and approvals.

Legal Proceedings

• The document mentions the risk of legal proceedings that may be instituted against Distoken, Youlife, Pubco, or others following the announcement of the Business Combination, but does not detail any specific ongoing proceedings.

Related Party Transactions

• Xiaosen Sponsor LLC, a Cayman Islands limited liability company, is a party to the Business Combination Agreement, which is a typical related party in SPAC transactions.

Stakeholder Impact

• Shareholders of Distoken: Advised to read the definitive proxy statement/prospectus for important information regarding the Business Combination and their interests.
• Investors (Subscribers): Committed to purchasing $27 million in Pubco shares, subject to the Business Combination's completion.
• Employees of Youlife: Potential impact from the business combination on current plans and operations, and the ability of Pubco to source and retain talent.
• Management of Distoken, Youlife, and Pubco: Involved in the execution and completion of the Business Combination.

Next Steps

• Completion of the Business Combination between Distoken and Youlife, with Pubco serving as the parent company.
• Consummation of the private placement simultaneously with the closing of the Business Combination.

Key Dates

Keywords

Distoken Acquisition Corporation, Youlife Group Inc., Business Combination, SPAC, Merger, Private Placement, Subscription Agreement, SEC Filing, Form 8-K, Proxy Statement, Nasdaq